Return to VISN 1 MIRECC Staff page

Robert A. Rosenheck, M.D.

Dr. Rosenheck is the Senior Investigator in Health Services Research at the New England MIRECC where his research focuses on issues of substance abuse among homeless Veterans. He is also Professor of Psychiatry and of Public Health and at the Child Study Center at Yale School of Medicine where he is Director of the Division of Mental Health Services and Outcomes Research in the Department of Psychiatry. He is an internationally known mental health service researcher who is a leader in cost-effectiveness studies of behavioral health interventions and in monitoring quality of care and other aspects of the performance of large health care systems.

He was responsible for the cost-effectiveness components of the recent NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia and Alzheimer’s disease trials. As founding Director of the Department of Veterans Affairs Northeast Program Evaluation Center, he spent 22 years training, evaluating, disseminating, and monitoring innovative mental health programs across the VA health care system. He has been a prime architect of national VA collaborative programs with both the U.S. Department of Housing and Urban Development and the Social Security Administration. He also directed both the client-level evaluation of the ACCESS program for homeless mentally ill Americans for the Substance Abuse and Mental Health Services Administration of the Department of Health and Human Services and the joint HUD-HHS-VA Collaborative Initiative on Chronic Homelessness.

He has published more than 600 scientific papers on topics such as performance evaluation of large mental health systems, mental health quality of care, the causes of homelessness, the organization and financing of mental health services, and the cost-effectiveness of psychosocial and psychopharmacological treatments of serious mental illnesses, homelessness, and PTSD among war Veterans. He has received awards for his work from both the American Psychiatric Association and the American Public Health Association.